vascular access thrombosis

vascular access thrombosis

Nursing A thrombus which forms at the site of vascular access
References in periodicals archive ?
During 3 years of self-care hemodialysis, persistent complications of vascular access thrombosis occurred.
1999), with vascular access thrombosis the most frequent cause (Brunet et al.
However, no relationship has yet been found between the presence of ACL and vascular access thrombosis (Brunet et al.
Others believe that rHuEPO therapy does not cause increased vascular access thrombosis (Besarb, Medina, Musial, Picarello, & Michael, 1990; Culp, Flanigan, Taylor, & Rothstein, 1995; De Marchi et al.
This study asked the question: Are the occurrences of vascular access thrombosis and hospitalization higher in chronic hemodialysis patients with Hcts [is greater than] 36% compared to those [is less than] 36%?
There are several causes of vascular access thrombosis, including venous stenosis, excessive post-dialysis fistula compression, hypotension, hypovolemia, fistula compression due to sleeping position, hypercoaguability, and arterial stenosis (Fan & Schwab, 1992).
However, it is not clear that the changes in these parameters that affect hemostasis are responsible for an increased incidence of vascular access thrombosis (Standage et al.
Some research has indicated a causal relationship between rHuEPO therapy and vascular access thrombosis.
1993) that the increased incidence of vascular access thrombosis is more apparent in grafts than in AVFs.
5 events/patient/year in a separate study of 1,111 patients not on rHuEPO and concluded that rHuEPO does not cause vascular access thrombosis (Eschbach et al.
The consensus among these three studies is that rHuEPO does not increase vascular access thrombosis.
In a 5-year study of 79 patients before and after rHuEPO therapy, the incidence of vascular access thrombosis decreased from 0.